You just read:

Revestive(R) (Teduglutide) Receives European Marketing Authorization for the Treatment of Adults With Short Bowel Syndrome (SBS)

News provided by

Takeda Pharmaceutical Company Limited

04 Sep, 2012, 12:00 BST